251 related articles for article (PubMed ID: 28364113)
1. [Research progress in vasculogenic mimicry in
multiple tumors].
Bai J; Xu Z; Liao C; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):357-364. PubMed ID: 28364113
[TBL] [Abstract][Full Text] [Related]
2. Advanced research on vasculogenic mimicry in cancer.
Qiao L; Liang N; Zhang J; Xie J; Liu F; Xu D; Yu X; Tian Y
J Cell Mol Med; 2015 Feb; 19(2):315-26. PubMed ID: 25598425
[TBL] [Abstract][Full Text] [Related]
3. Vasculogenic mimicry and tumor metastasis.
Zhang J; Qiao L; Liang N; Xie J; Luo H; Deng G; Zhang J
J BUON; 2016; 21(3):533-41. PubMed ID: 27569069
[TBL] [Abstract][Full Text] [Related]
4. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.
Liu Q; Qiao L; Liang N; Xie J; Zhang J; Deng G; Luo H; Zhang J
J Cell Mol Med; 2016 Sep; 20(9):1761-9. PubMed ID: 27027258
[TBL] [Abstract][Full Text] [Related]
5. Contribution of cancer stem cells to tumor vasculogenic mimicry.
Yao XH; Ping YF; Bian XW
Protein Cell; 2011 Apr; 2(4):266-72. PubMed ID: 21533771
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
Sun B; Zhang D; Zhao N; Zhao X
Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
[TBL] [Abstract][Full Text] [Related]
8. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.
Li S; Meng W; Guan Z; Guo Y; Han X
Biomed Pharmacother; 2016 May; 80():127-135. PubMed ID: 27133049
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase mediates transforming growth factor-β1-induced vasculogenic mimicry formation: involvement of the epithelial-mesenchymal transition and cancer stemness activity.
Zhang X; Zhang J; Zhou H; Liu G; Li Q
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):411-420. PubMed ID: 32296834
[TBL] [Abstract][Full Text] [Related]
10. Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
Li Y; Sun B; Zhao X; Zhang D; Wang X; Zhu D; Yang Z; Qiu Z; Ban X
Exp Mol Pathol; 2015 Apr; 98(2):136-44. PubMed ID: 25661888
[TBL] [Abstract][Full Text] [Related]
11. Signalling pathways in vasculogenic mimicry.
Paulis YW; Soetekouw PM; Verheul HM; Tjan-Heijnen VC; Griffioen AW
Biochim Biophys Acta; 2010 Aug; 1806(1):18-28. PubMed ID: 20079807
[TBL] [Abstract][Full Text] [Related]
12. Epithelial Mesenchymal Transition and Vascular Mimicry in Breast Cancer Stem Cells.
Kotiyal S; Bhattacharya S
Crit Rev Eukaryot Gene Expr; 2015; 25(3):269-80. PubMed ID: 26558950
[TBL] [Abstract][Full Text] [Related]
13. Vasculogenic mimicry in carcinogenesis and clinical applications.
Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C
J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
Cao Z; Shang B; Zhang G; Miele L; Sarkar FH; Wang Z; Zhou Q
Biochim Biophys Acta; 2013 Dec; 1836(2):273-86. PubMed ID: 23933263
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways in tumor vasculogenic mimicry.
Vartanian AA
Biochemistry (Mosc); 2012 Sep; 77(9):1044-55. PubMed ID: 23157265
[TBL] [Abstract][Full Text] [Related]
17. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.
Delgado-Bellido D; Serrano-Saenz S; Fernández-Cortés M; Oliver FJ
Mol Cancer; 2017 Mar; 16(1):65. PubMed ID: 28320399
[TBL] [Abstract][Full Text] [Related]
18. The origins of vacularization in tumors.
Liu J; Huang J; Yao WY; Ben QW; Chen DF; He XY; Li L; Yuan YZ
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2559-65. PubMed ID: 22652798
[TBL] [Abstract][Full Text] [Related]
19. Vasculogenic mimicry: a novel target for glioma therapy.
Chen YS; Chen ZP
Chin J Cancer; 2014 Feb; 33(2):74-9. PubMed ID: 23816560
[TBL] [Abstract][Full Text] [Related]
20. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
